Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPARγ and NF-κB pathways

International Journal of Molecular Medicine

Volumn 36, Issue 2, 2015, Pages 449-454

  Deng, Xinchao ^a   Zhang, Ping ^a   Liang, Tingting ^a   Deng, Suye ^b   Chen, Xiaojie ^a   Zhu, Lin ^a  

^a SHANDONG UNIVERSITY   (China)

^b Pingdu Traditional Chinese Medicine Hospital of Shandong Province   (China)

Author keywords

M1 M2 polarization; Macrophages; Nuclear factor B; Ovarian cancer stem cells; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ARGINASE 1; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MANNOSE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CANCER STEM CELL; CELL RENEWAL; COCULTURE; FEMALE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; POLARIZATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; IMMUNOLOGY; OVARY; OVARY TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEMALE; MACROPHAGES; MICE; NEOPLASTIC STEM CELLS; NF-KAPPA B; OVARIAN NEOPLASMS; OVARY; PPAR GAMMA; SIGNAL TRANSDUCTION;

EID: 84934290620     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2230     Document Type: Article

References (37)

1. Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X and Hamilton TC: Focus on epithelial ovarian cancer. Cancer Cell 5: 19-24, 2004.
2. Clarke-Pearson DL: Clinical practice. Screening for ovarian cancer. N Engl J Med 361: 170-177, 2009.
3. Schwartz PE: Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res 107: 99-118, 2002.
4. Ailles LE and Weissman IL: Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460-466, 2007.
5. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
6. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
7. Bapat SA, Mali AM, Koppikar CB and Kurrey NK: Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65: 3025-3029, 2005.
8. Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr and Skubitz AP: Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 93: 170-181, 2004.
9. Curley MD, Therrien VA, Cummings CL, et al: CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27: 2875-2883, 2009.
10. Wani AA, Sharma N, Shouche YS and Bapat SA: Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 25: 6336-6344, 2006.
11. Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, Alvarez RD, Zhang K, Conner M and Landen CN: Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 18: 869-881, 2012.
12. Alvero AB, O'Malley D, Brown D, Kelly G, Garg M, Chen W, Rutherford T and Mor G: Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 106: 599-608, 2006.
13. Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC, Oidtman J, Silasi DA and Mor G: Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 27: 2405-2413, 2009.
14. Albini A, Cesana E and Noonan DM: Cancer stem cells and the tumor microenvironment: Soloists or choral singers. Curr Pharm Biotechnol 12: 171-181, 2011.
15. Stockmann C, Schadendorf D, Klose R and Helfrich I: The impact of the immune system on tumor: Angiogenesis and vascular remodeling. Front Oncol 4: 69, 2014.
16. Chouaib S, Kieda C, Benlalam H, Noman MZ, Mami-Chouaib F and Rüegg C: Endothelial cells as key determinants of the tumor microenvironment: Interaction with tumor cells, extracellular matrix and immune killer cells. Crit Rev Immunol 30: 529-545, 2010.
17. Mantovani A and Sica A: Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237, 2010.
18. Ma W, Ma J, Xu J, Qiao C, Branscum A, Cardenas A, Baron AT, Schwartz P, Maihle NJ and Huang Y: Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment. Cell Cycle 12: 88-97, 2013.
19. Alvero AB, Chen R, Fu HH, et al: Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8: 158-166, 2009.
20. Alvaro T, de la Cruz-Merino L, Henao-Carrasco F, Villar Rodríguez JL, Vicente Baz D, Codes Manuel de Villena M and Provencio M: Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. J Biomed Biotechnol 2010: 1-17, 2010.
21. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B and Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811, 2000.
22. Cretu A and Brooks PC: Impact of the non-cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities. J Cell Physiol 213: 391-402, 2007.
23. Oluwadara O, Giacomelli L, Brant X, Christensen R, Avezova R, Kossan G and Chiappelli F: The role of the microenvironment in tumor immune surveillance. Bioinformation 5: 285-290, 2010.
24. Piersma SJ: Immunosuppressive tumor microenvironment in cervical cancer patients. Cancer Microenviron 4: 361-375, 2011.
25. Sautès-Fridman C, Cherfils-Vicini J, Damotte D, Fisson S, Fridman WH, Cremer I and Dieu-Nosjean MC: Tumor microenvironment is multifaceted. Cancer Metastasis Rev 30: 13-25, 2011.
26. Mantovani A, Schioppa T, Porta C, Allavena P and Sica A: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25: 315-322, 2006.
27. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003.
28. Mantovani A, Locati M, Vecchi A, Sozzani S and Allavena P: Decoy receptors: A strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22: 328-336, 2001.
29. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006.
30. Porcheray F, Viaud S, Rimaniol AC, Léone C, Samah B, Dereuddre-Bosquet N, Dormont D and Gras G: Macrophage activation switching: An asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489, 2005.
31. Murray PJ and Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737, 2011.
32. Gao S, Mao F, Zhang B, et al: Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways. Exp Biol Med (Maywood) 239: 366-375, 2014.
33. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC and Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819, 1995.
34. Willson TM, Brown PJ, Sternbach DD and Henke BR: The PPARs: From orphan receptors to drug discovery. J Med Chem 43: 527-550, 2000.
35. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J and Staels B: Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580, 1998.
36. Chinetti G, Fruchart JC and Staels B: Peroxisome proliferator-activated receptors: New targets for the pharmacological modulation of macrophage gene expression and function. Curr Opin Lipidol 14: 459-468, 2003.
37. Chinetti G, Fruchart JC and Staels B: Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49: 497-505, 2000.